You are using an older browser version. Please use a supported version for the best MSN experience.

COVID-19 treatment Bamlanivimab goes unused

COVID-19 vaccines have come fast but treatments for the disease are still limited. When a Canadian company developed Bamlanivimab, a new monoclonal antibody drug, Ottawa spent millions on doses. But after the rush to buy them they've sat on shelves for months, unused.

UP NEXT

UP NEXT

image beaconimage beaconimage beacon